C

Citius Oncology Inc
NASDAQ:CTOR

Watchlist Manager
Citius Oncology Inc
NASDAQ:CTOR
Watchlist
Price: 1.39 USD 21.93%
Market Cap: 116.1m USD

Wall Street
Price Targets

CTOR Price Targets Summary
Citius Oncology Inc

Wall Street analysts forecast CTOR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTOR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
336% Upside
Average
Price Target
6.12 USD
340% Upside
Highest
Price Target
6.3 USD
353% Upside
Citius Oncology Inc Competitors:
Price Targets
688105
Nanjing Vazyme Biotech Co Ltd
45% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
31% Upside
GLPG
Galapagos NV
11% Upside
RPTX
Repare Therapeutics Inc
42% Upside
RCUS
Arcus Biosciences Inc
49% Upside
4599
StemRIM Inc
183% Upside
AMRN
Amarin Corporation PLC
11% Downside
URGN
Urogen Pharma Ltd
58% Upside

Revenue
Forecast

Revenue Estimate
Citius Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Citius Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Citius Oncology Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CTOR's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CTOR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Back to Top